http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1782168-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f9e7aa6d128540cb617e4fceb7ed4f9 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
filingDate | 1991-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1992-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab1c3a349ce828d414dcf609f978b42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67298a94f51a429760884a3e214e99a0 |
publicationDate | 1992-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-1782168-C |
titleOfInvention | Method for treating migraine |
abstract | The invention relates to medicine, namely to neurology and can be used .. i-i-i-V 1e. jFJLuliti Jt SEf SV ai is intended for the treatment of severe forms of migraine occurring in combination with neurosis and early cerebral atherosclerosis and with hypertensive syndrome in people with intense mental work. The method allows to reduce the side effect of drug therapy and to shorten the treatment time. For this, during the period of adaptation, migraine patients undergo endonasal electrophoresis of a 0.1% solution of obzidan for 5 days daily, then every other day in combination with hydrogen sulfide baths. |
priorityDate | 1991-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.